Logo image of NANO.PA

NANOBIOTIX (NANO.PA) Stock Overview

Europe - EPA:NANO - FR0011341205 - Common Stock

10.18 EUR
-0.64 (-5.91%)
Last: 9/19/2025, 11:08:40 AM

NANO.PA Key Statistics, Chart & Performance

Key Statistics
52 Week High10.94
52 Week Low2.62
Market Cap487.84M
Shares47.92M
Float40.55M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-1.44
PEN/A
Fwd PEN/A
Earnings (Next)09-16 2025-09-16
IPO10-29 2012-10-29
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


NANO.PA short term performance overview.The bars show the price performance of NANO.PA in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 50 100 150 200

NANO.PA long term performance overview.The bars show the price performance of NANO.PA in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150

The current stock price of NANO.PA is 10.18 EUR. In the past month the price increased by 30.52%. In the past year, price increased by 139.91%.

NANOBIOTIX / NANO Daily stock chart

NANO.PA Competitors/Peers

The largest stocks on the EU markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
4AB.DE ABBVIE INC 20.94 331.41B
AMG.DE AMGEN INC 12.67 125.90B
GIS.DE GILEAD SCIENCES INC 14.67 119.24B
1VRTX.MI VERTEX PHARMACEUTICALS INC 23.36 85.81B
VX1.DE VERTEX PHARMACEUTICALS INC 23.05 84.70B
ARGX.BR ARGENX SE 84.82 37.94B
1AE.DE ARGENX SE 84.62 37.86B
22UA.DE BIONTECH SE-ADR N/A 19.80B
1BIIB.MI BIOGEN INC 9.34 18.55B
IDP.DE BIOGEN INC 9.08 18.04B
1EXEL.MI EXELIXIS INC 18.85 8.93B
0QF.DE MODERNA INC N/A 8.47B

About NANO.PA

Company Profile

NANO logo image Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. The company is headquartered in Paris, Ile-De-France and currently employs 108 full-time employees. The company went IPO on 2012-10-29. The firm designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. The company develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The firm's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.

Company Info

NANOBIOTIX

60 rue de Wattignies

Paris ILE-DE-FRANCE FR

Employees: 108

NANO Company Website

NANO Investor Relations

Phone: 33140260470

NANOBIOTIX / NANO.PA FAQ

What is the stock price of NANOBIOTIX today?

The current stock price of NANO.PA is 10.18 EUR. The price decreased by -5.91% in the last trading session.


What is the ticker symbol for NANOBIOTIX stock?

The exchange symbol of NANOBIOTIX is NANO and it is listed on the Euronext Paris - Matif exchange.


On which exchange is NANO.PA stock listed?

NANO.PA stock is listed on the Euronext Paris - Matif exchange.


What is the price forecast or stock price prediction for NANOBIOTIX stock?

12 analysts have analysed NANO.PA and the average price target is 11.41 EUR. This implies a price increase of 12.05% is expected in the next year compared to the current price of 10.18. Check the NANOBIOTIX stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is NANOBIOTIX worth?

NANOBIOTIX (NANO.PA) has a market capitalization of 487.84M EUR. This makes NANO.PA a Small Cap stock.


How many employees does NANOBIOTIX have?

NANOBIOTIX (NANO.PA) currently has 108 employees.


What are the support and resistance levels for NANOBIOTIX (NANO.PA) stock?

NANOBIOTIX (NANO.PA) has a support level at 8.03. Check the full technical report for a detailed analysis of NANO.PA support and resistance levels.


Is NANOBIOTIX (NANO.PA) expected to grow?

The Revenue of NANOBIOTIX (NANO.PA) is expected to grow by 5.81% in the next year. Check the estimates tab for more information on the NANO.PA EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy NANOBIOTIX (NANO.PA) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does NANOBIOTIX (NANO.PA) stock pay dividends?

NANO.PA does not pay a dividend.


When does NANOBIOTIX (NANO.PA) report earnings?

NANOBIOTIX (NANO.PA) will report earnings on 2025-09-16.


What is the Price/Earnings (PE) ratio of NANOBIOTIX (NANO.PA)?

NANOBIOTIX (NANO.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.44).


NANO.PA Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to NANO.PA. When comparing the yearly performance of all stocks, NANO.PA is one of the better performing stocks in the market, outperforming 99.15% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

NANO.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to NANO.PA. NANO.PA has a bad profitability rating. Also its financial health evaluation is rather negative.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NANO.PA Financial Highlights

Over the last trailing twelve months NANO.PA reported a non-GAAP Earnings per Share(EPS) of -1.44. The EPS decreased by -33.33% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -101.06%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%-250%
Sales Q2Q%-150.07%
EPS 1Y (TTM)-33.33%
Revenue 1Y (TTM)-138.62%

NANO.PA Forecast & Estimates

12 analysts have analysed NANO.PA and the average price target is 11.41 EUR. This implies a price increase of 12.05% is expected in the next year compared to the current price of 10.18.

For the next year, analysts expect an EPS growth of 41.35% and a revenue growth 5.81% for NANO.PA


Analysts
Analysts86.67
Price Target11.41 (12.08%)
EPS Next Y41.35%
Revenue Next Year5.81%

NANO.PA Ownership

Ownership
Inst Owners27.55%
Ins Owners0.64%
Short Float %N/A
Short RatioN/A